- Home
- CNM vs HALO Comparison
CNM vs HALO Comparison
Compare CNM & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNM | HALO |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Durable Goods | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 7.4B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNM | HALO |
|---|---|---|
| Price | $55.96 | $62.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 12 |
| Target Price | $60.82 | ★ $73.33 |
| AVG Volume (30 Days) | ★ 3.2M | 2.5M |
| Earning Date | 12-09-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.81 | ★ 56.68 |
| EPS | 2.28 | ★ 4.74 |
| Revenue | ★ $7,764,000,000.00 | $1,242,852,000.00 |
| Revenue This Year | $4.45 | $34.83 |
| Revenue Next Year | $4.43 | $24.84 |
| P/E Ratio | $24.64 | ★ $13.14 |
| Revenue Growth | 8.09 | ★ 31.19 |
| 52 Week Low | $43.18 | $46.26 |
| 52 Week High | $67.18 | $79.50 |
Technical Indicators
Market Signals| Indicator | CNM | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 70.80 | 34.09 |
| Support Level | $44.59 | $61.23 |
| Resistance Level | $50.10 | $63.26 |
| Average True Range (ATR) | 1.68 | 2.42 |
| MACD | 1.17 | -0.79 |
| Stochastic Oscillator | 90.74 | 7.60 |
Price Performance
Historical ComparisonAbout CNM Core & Main Inc.
Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.